pure atherectomi initi outperform
initi coverag inc csi outperform
rate price target csi manufactur market
diamondback orbit atherectomi system use debulk arteri prior
definit therapi coronari peripher arteri diseas case cad/pad
compani current annual sale grow
clip multipl lever sustain growth cross-sel product new
product initi growth intern market current coronaviru
pandem introduc short-term uncertainti macro-level
pictur accordingli reflect street-low sale
estim contend fundament stori chang make
attract long-term investor
larg market debulk use atherectomi well-accept cad-pad
procedur increment improv outcom definit therapi
stent dcb market howev fragment use cad
procedures/yr pad procedures/yr estim
csi account unit share cad
pad market respect grow y/i
valu proposit diamondback uniqu moa resid sand
calcifi lesion use eccentr diamond burr multipl clinic trial
shown lower advers event enabl better stent placement
improv clinic outcom favor reimburs climat allow
y/i growth pad side cad side
growth initi csi initi sustain growth includ increas
revenues/cas cross-sel accessori product expand intern
market introduc new product percutan ventricular assist
devic pvad success could open new worth hundr
million dollar conduct clinic trial like eclips
success could chang practic pattern within coronari segment
coronaviru pandem introduc signific short-term uncertainti
disloc hospit procedur foot-traff outpati clinic due travel
restrict sale rep limit entri hospit within backdrop
point limb salvag cardiac procedur symptom exempt
restrict fundament backdrop chang csi
valuat given coronaviru backdrop deliber conserv
estim
respect extent csi mitig short-term impact
room upward revis henc initi fundament bullish stanc
year price histori
manufactur orbit atherectomi
treat peripher
analyst certif import disclosur see disclosur
organ growth continu compound-annual-growth-rate rang
pvad call option stori
market growth repres increment
peripher segment growth continu rang
coronari segment growth continu rang
increment revenues/cas keep increas introduct
pvad contribut anoth year
eclips trial complet enrol
addit detail pvad fim success
eclips trial overwhelm success
pvad fim yield good result
accessori product uptak strong
price declin coronari peripher segment
pt repres sale estim aggreg med-tech univers current trade forecast
sale compound-annual-growth-rate give premium multipl growth driver
csi compet number larger player philip henc execut risk integr part
stori
biggest short-term risk horizon unknown collater damag coronaviru accordingli lower
number compani recent withdrawn guidanc due account potenti impact
eclips repres larg opportun stori potenti chang practic pattern move forward
tabl content
vessel prep atherectomi
implic arteri calcif
challeng treat arteri calcif
vessel prep cad
vessel prep pad
peripher arteri diseas pad coronari arteri diseas cad clinic
manifest system atherosclerosi limb heart respect
associ signific morbid mortal us estim
pad patient roughli one-quart claudic suffer
critic limb ischemia pad respons hospit admissions/yr
us physician offic visits/yr deaths/yr pad preval
patient diabet without diabet approxim diabet patient
concomit pad major amput rate higher diabet non-
diabet rel mortal rate sever pad patient roughli
endovascular procedur perform per year us
sort calcifi lesion outsid us anoth pad procedur
perform world-wide pad market includ balloon accessori product
stent atherectomi estim around us anoth ou
similarli cad lead caus death us death
relat cad year cad culprit estim one-third death
popul older year besid mortal case myocardi
infarct mi occur annual us due cad yearli incid rate
approxim case per peopl clinic sequela mi
equal devast patient develop heart failur within year
seriou mi us estim catheter-bas coronari procedur
perform per year treat cad util varieti treatment tool angioplasti
stent overal cad market percutan approach us current
estim predominantli use drug-elut stent two
market view interconnect underli caus remain similar
hypertens diabet obesityand rise incid etiolog impli
healthi total address market moreov pad patient
concomit cad henc make respect tam attract
atherectomi use padcad
atherectomi refer endovascular remov atheromat tissu cut
shave drill pulver sand result enlarg treat
lumen besid lumen gain remov gunk arteri anoth aspect
atherectomi chang arteri complianc turn mitig neointim
injuri encount deliveri definit therapi essenc
atherectomi vessel-prep techniqu design increment improv outcom
definit therapi drug-coat balloon stent time
allow eas procedur challeng deliveri definit therapi atherectomi
devic classifi follow four categori base upon mechan
action excision direct atherectomi da orbit atherectomi oa laser
atherectomi rotat atherectomi current atherectomy-onli market us
estim cad pad segment grow
y/i clip math suggest coronari pci procedur us
current use atherectomi definit therapi pad
case use atherectomi thu remain ampl opportun improv outcom
note atherectomi modal well-recogn payer
establish reimburs code obl set led prolifer
procedur outpati set thu structur landscap overal
vascular calcif cadpad problem
vascular calcif coronari peripheri direct correl
age diabet obes exist evid indic patient
year age almost calcium least coronari arteri bed two-third
calcif coronari arteri bed time cad patient also
concomit pad make appeal pci
procedur done us per year moderatesever calcium estim
preval rate sever calcium case pad side estim
preval sever calcium us treat vascular calcif
coronari peripheri challeng date lack true lack
compar assess outcom lack durabl outcom particular
therapi yield fragment marketplac especi pad oper
prefer lucr reimburs drive adopt necessarili long-term
outcom calcif restrict vessel expans result higher residu stenosi
lower procedur effect durabl calcif may impair
antiprolif effect dcb like act physic barrier drug penetr
addit calcif increas risk vascular complic follow
treatment includ dissect perfor distal embol restenosi pta
stent lack definit approach along lack durabl long term
outcom make fertil ground new technolog
challeng within atherectomi space
use atherectomi adjunct tool improv outcom definit therapi
well accept year clinic trial shown use
atherectomi result primari patenc rate target vessel one year
target lesion revascular tlr rate reduct amput rate
signific improv walk test patient reimburs
landscap atherectomi also favor inpati drg rate cad pad
rang outpati offic base lab obl set
pad case done also favor reimburs rang
state otherwis reimburs hindranc howev
cad case pad case current use form atherectomi
fragment landscap function differ mechan action tool
heterogen lesion cad pad lack compar effect trial
differ modal differ oper techniqu prefer
within fragment marketplac oass unit share coronari
peripher side therefor impli enough upsid de novo growth share gain
csi diamondback orbit atherectomi system util orbit eccentr
diamond-co crown end drive shaft power pneumat drive consol
orbit motion crown remov plaqu within diseas arteri segment
crown orbit debulk area increas increment speed area
increas unlik direct atherectomi requir multipl pass
slight rotat devic remov plaqu singl plane pass
plaqu physic remov nose cone orbit atherectomi requir singl
insert plaqu debulk occur crown advanc back forth
lesion diamond coat orbit crown fine granular textur
particl sand vessel wall small less apt caus
signific distal embol uniqu tool design combin procedur eas
led account unit share pad segment behind
turbohawk unit share cad side behind boston scientif rotabl
import evalu import clinic trial within pad
cad segment pad result liberti trial show higher incid
freedom amput lesion revascular three year result
complianc trial show statist signific reduct bailout stent
freedom target vessel revascular month cad result
orbit ii studi show use prior stent result low tlr/tvr rate
year high procedur success rate stent placement rel
low mace rate import compani cusp finish enrol
eclips trial random control trial rct evalu safeti
efficaci adjunct strategi prior stent placement sever calcifi
coronari lesion trial difficult-to-treat patient popul close finish
enrol studi result could present signific catalyst stori
csi core segmentscad padar current grow
year/year clip respect us constitut overal revenu gross
margin remain healthi within framework compani invest
variou initi sustain growth long haul initi
introduct accessori product guidewir balloon cathet etc could
allow revenues/cas intern market expans recent partnership
orbu neich europ medikit japan new product initi
percutan success could open new worth
hundr million dollar alon clinic trial eclips
success could chang practic pattern within coronari segment futur
bolt-on acquisit could anoth avenu growth especi pos
target market uniqu valu proposit debulk
calcifi arteri present csi uniqu long-term growth portfolio
valuat coronaviru
would irrespons mention gorilla room right fear
coronaviru pandem would nave look crystal ball
predict pandem subsid thing return semi-norm
within context note csi stock almost cut half despit
fundament shift valu proposit henc initi coverag
cardiovascular system outperform rate month price target
pt deriv use multipl sale estim
point obviou number lower compani recent
withdrawn sale guidanc state earlier
mani unknown current environ henc prudent
drastic conserv extent compani come
environ rel less impact probabl would rais
pro forma estim said current valuat allow entri growth-
orient investor stori good end-market good manag team good
call option new product initi factor inform rate pt
initi transmed outperform outperform also releas
base st paul mn develop market atherectomi
support product use peripher coronari procedur compani orbit
atherectomi system util rpm-depend diamond burr-coat sander
subject peer-review articl calcifi lesion peripheri
coronari compani employ roughli employe us direct
sale forc includ quota-carri sale repres clinic
specialist compani partnership arrang orbu neich europ
medikit japan compani current annual global
sale grow y/i grow incid obes diabet hypertens
lead rise rate peripher coronari arteri diseas csi atherectomi
solut therefor view adjunct therapi facilit improv
definit therapi stent angioplasti
diamondback coronari
csi core technolog orbit atherectomi treat symptomat peripher
coronari arteri diseas diamondback orbit atherectomi system util
orbit eccentr diamond-co crown end drive shaft power
pneumat drive consol shaft crown advanc pre-plac
proprietari guidewir viperwir orbit motion crown remov plaqu
within diseas arteri segment crown orbit debulk area increas
increment speed area increas comparison rotat
atherectomi use concentr rotat burr lumin gain larg burr size
util chang rotat speed burr result signific
increas debulk area happen orbit atherectomi larger lumen
desir larger burr must deploy
orbit atherectomi perform guidewir contrast wire
rotat atherectomi larger diamet guidewir make easier advanc across
tight stenosi support given especi contralater approach util
support guidewir essenti track adjunct devic
flow stenos total occlud vessel continu
flush particul downstream may reduc device-gener heat unlik direct
atherectomi perform use multipl pass slight rotat devic
remov plaqu singl plane pass plaqu remov pack
nose cone sever pass cathet remov empti nose cone
orbit atherectomi requir singl insert plaqu debulk occur
crown advanc back forth lesion diamond coat orbit
crown fine granular textur particl sand vessel wall
small less apt caus signific distal embol
exhibit order diamondback coronari orbit atherectomi system close-up view differ crown bench test lumen gain correl
travers speed peripher atherectomi
note exhibit continu next two page
note exhibit continu next page
orbit action abil increas orbit circumfer increas
orbit speed result substanti time save atherectomi procedur
diamond crown use csi orbit atherectomi devic primarili use calcifi
fibrot smaller arteri knee well femoropoplit vessel
calcifi coronari arteri viperwir good pushabl torqu respons
diamondback requir use proprietari guidewir
diamondback rang crown size oper three preset rotat
speed import devic oper familiar type crown
avail systemclass solid microa well control touch
screen interfac display inform control preset speed low
medium high start low speed follow medium high need
advanc crown slowli usual protocol small crown initi deploy
speed ramp maximum order get maximum lumen
diamet solid crown address issu addit lumin gain larger vessel
solid crown achiev mm lumen wherea similarli size classic
crown achiev mm lumen diamond coat cover entir crown
increas sand surfac area debulk addit diamond coat
tip devic improv penetr capac difficult chronic total
occlus classic crown mm crown use treat smaller distal
one excit aspect csi stori view csi estim
coronari case use also use percutan ventricular
assist devic hemodynam support henc rational organ develop
pvad captur increment revenue/cas make perfect sens howev
much known devic design except leverag csi core
compet motor control spin cabl flow lpm cross
profil fr cathet profil fr archimed screw design
motor resid outsid bodi use lv placement
base compani commentari multipl anim studi complet
success pre-submiss meet complet underway fda
first-in-human fih trial expect view could biggest
call option stori given extens work percutan space csi
strategi look interest given current modal suffer high
mortal rate hemolysi tag medic journal articl
scientif confer present high advers event modal
fail pivot trial yet receiv pma reason map
code transcathet heart valv mismatch reimburs code
view primari driver use current percutan vad clinic
util per se csi abl success develop product target rel
dissatisfi clinician base interest note unfortun note
detail avail product design sink teeth make
engin assess henc factor valuat howev
note csi get right pvad could new opportun worth hundr
million dollar size
pad result either atherosclerot inflammatori process caus lumen
narrow stenosi thrombu format usual associ underli
atherosclerot diseas condit aris increas vessel
resist lead reduct distal arteri pressur blood flow
circul leg deriv common femor arteri continu
extern iliac arteri common femor arteri branch deep femor
superfici femor arteri deep femor suppli blood flow thigh
receiv approxim common femor arteri flow superfici femor
arteri sfa continu leg becom poplit arteri
knee major arteri termin poplit arteri anterior
posterior tibial arteri suppli blood flow lower leg foot process
atherosclerosi caus intim thicken plaqu format decreas
effect radiu afflict arteri segment although atherosclerosi gener
diffus process affect arteri degre arteri segment
limb often undergo greater stenosi other therefor common find stenot
lesion associ specif arteri extern iliac common femor sfa
exhibit anatom site pad
although lumin narrow clearli contribut function limit grow bodi
data support import contribut cellular chang vasculatur well
skelet muscl sever studi shown impair endotheli vasodil
respons pad includ brachial arteri demonstr system
dysfunct rather sole local phenomenon chang skelet muscl seem
occur extrem affect pad includ chang overal mass
densiti well cellular chang energet metabol mitochondri
dysfunct may lead gener reactiv oxygen speci lead inflamm
acceler cellular damag exhibit exercis train shown
sever potenti mechan benefit address local system derang
implic function impair
exhibit mechan function impair pad
base poiseuil equat decreas vessel radiu increas resist
fourth power chang radiu therefor reduct radiu one-half
normal radiu caus resist increas factor hemodynam
would caus flow decreas factor assum perfus pressur
constant laminar flow condit prevail resist segment
repres total resist flow segment one multipl in-seri
segment howev major arteri limb circul seri
parallel branch stenot lesion gener radiu decreas
result signific hemodynam effect critic stenosi
furthermor given reduct radiu longitudin pressur drop across
length lesion significantli augment turbul occur
pad lead limb ischemia mild moder pad increas resist
flow lead decreas maxim flow capac limb exercis decreas
activ hyperemia result ischem pain exercis term
intermitt claudic pain caus tissu hypoxia result high
oxygen demand met adequ increas oxygen deliveri
increas blood flow word reduct oxygen supply/demand
ratio metabolit form anaerob condit muscl stimul pain
receptor muscl inadequ oxygen suppli exercis also lead
muscl weak fatigu stenot arteri lesion may may alter rest blood
flow atherosclerosi diseas process occur year circul distal
stenot lesion often undergo collater reduc resist
furthermor even acut reduct perfus pressur lead fall distal vascular
resist normal blood flow mechan autoregul
exhibit approxim level symptomat pad
patient pad increas risk system ischem event associ
comorbid cad cerebrovascular diseas primari symptom pad pain
occur physic activ typic local distal stenot vessel pain
caus patient often come halt walk symptom refer
intermitt claudic typic claudic reliev paus walk
also ensur feet remain lower level heart restor part
circul defect lead tissu hypoxia pain feet
result skin becom cold pale distal stenosi often palpabl
puls bodi gener overcom minor stenosi collater circul
full panel symptom manifest stenosi actual
explain extrem high percentag asymptomat pad patient diminish
circul constitut fertil ground ulcer heal disord necrosi gangren
affect area blood flow distal complet block situat call
critic limb ischemia aris requir drastic surgic endovascular
exhibit stage pad symptom progress
morbid mortal pad
risk factor pad includ diabet hypertens hyperlipidemia smoke
correl consid
pad respons hospit admissions/year
physician offic visits/year deaths/year
pad preval patient diabet without diabet
approxim diabet patient concomit pad
major amput rate higher diabet non-diabet
smoke cigarettes/day result increas pad
rel mortal rate sever pad patient
exhibit order overlap atherosclerot diseas rel mortal rate
symptomat pad patient also suffer significantli limb-rel morbid high-
risk patient symptomat pad requir peripher intervent
next year rate acut limb ischemia ali amput similar
rate stroke mi high-risk patient like like suffer
limb-rel morbid suffer acut system ischem event patient
pad usual receiv prevent intervent includ lifestyl modif
optim manag atherosclerot risk factor benefit statin therapi may
extend beyond reduct mi stroke cardiovascular death improv function
statu reduc limb vascular event amput anti-platelet therapi also
reduc risk mi stroke cardiovascular death patient symptomat
pad relev report intervent therapi atherectomi stent
cancerhodgkinsdiseasepadcolon rectalcancerlung cancer outperform
exhibit treatment paradigm pad
sourc www cdc gov chilton et al pathophysiolog coronari heart diseas
previous consid cholesterol storag diseas current understand
atherogenesi complex interact risk factor includ cell arteri wall
blood molecular messag exchang use organ theme
emerg first laboratori studi gain currenc clinic accord
inflamm major role stage atherogenesi inflamm also particip
local myocardi system complic atherosclerosi arteri
endothelium encount certain bacteri product risk factor divers
dyslipidemia vasoconstrictor hormon inculp hypertens product
glycoxid associ hyperglycemia proinflammatori cytokin deriv
excess adipos tissu cell augment express adhes molecul
promot stick blood leukocyt inner surfac arteri wall
transmigr adher leukocyt depend larg part express
chemoattract cytokin regul signal associ tradit emerg
risk factor atherosclerosi
resid arteri intima blood leukocytesmainli mononuclear
phagocyt lymphocytescommun endotheli smooth muscl cell
smc endogen cell arteri wall major messag exchang among
cell type involv atherogenesi depend mediat inflamm immun
includ small molecul includ lipid mediat prostanoid
deriv arachidon acid leukotrien autacoid histamin
classic regul vascular tone increas vascular permeabl recent much
attent focus protein mediat inflamm immun includ
cytokin complement compon
injuri infect disrupt normal endotheli function initi format
atherosclerot lesion known fatti streak fatti streak typic consist
macrophag cell embed thin layer lipid arteri wall
macrophag engulf lipid becom activ foam cell releas array
chemoattract molecul cytokin growth factor lymphocyt
attract lesion turn add pool effector molecul expand
perpetu inflammatori respons cycl repeat plaqu develop
fatti core cover fibrou matrix stabil structur plaqu becom
thicker arteri wall respond remodel gradual dilat maintain
diamet vessel lumen eventu macrophag may stimul releas
metalloproteinas degrad fibrou cap render plaqu vulner
ruptur although sever type plaqu result seriou coronari event
retrospect analys demonstr fatal acut myocardi
infarct sudden coronari death attribut plaqu ruptur plaqu
eros observ surpris plaqu destabil often
accompani releas prothrombot factor howev type atherosclerot
plaqu result coronari event sudden death vulner plaqu defin
thrombosis-pron risk rapid progress exhibit combin
follow activ inflamm thin cap larg lipid core endotheli denud
superfici platelet aggreg fissur greater stenosi
thrombot statu blood electr instabl myocardium
import ultim outcom patient
exhibit progress cad patholog composit lesion respons coronari occlus death
deep dive variou surgic approach treat coronari arteri diseas
beyond scope report on-pump off-pump bypass surgeri routin
done us depend patient characterist csi orbit atherectomi
relev case percutan coronari intervent procedur
angioplasti stent
vessel prep atherectomi
goal vessel prepar includ remov calcif modifi plaqu
gain lumen definit therapi drug-elut stent drug-
coat balloon plain old balloon may efficaci deliv deliv
lumen gain blood flow calcium particular deserv special consider may
limit vessel expans caus injuri drug effect develop
leave-nothing-behind strategi vessel prepar key focu
intervent dedic pretreat lesion mandatori plaqu modif
import come local drug deliveri lesion via either balloon stent
matter remov excess materi allow better stent expans adequ
lesion pretreat enhanc final outcom definit therapi role
atherectomi come play definit atherectomi vessel-prep techniqu
physic remov materi lesion site
given report orbit atherectomi focu attent core
strength technolog competit matrix seen orbit
atherectomi competit strength vessel prep calcifi lesion
coronari peripher side note orbit atherectomi contra-
indic in-stent restenosi isr far know excim laser
label in-stent restenosi henc calcul factor isr vis-
-vi orbit atherectomi mechan vessel prepar affect procedur
success rate long-term outcom consequ vessel prepar shift
trend consist element treatment algorithm vessel prepar minim
risk dissect maxim lumin gain prepar vessel bed stent
vascular mimet implant and/or local drug deliveri vessel prepar
consid regardless whether lesion stenot occlus especi
crucial calcium present challeng vessel prep approach includ
uniform definit vessel prep simplest sens vessel prep
process chang arteri complianc allow full dilat without aggress balloon
inflat either drug-coat balloon angioplasti dcb nondrug simpl poba
balloon technolog stent effect dilat vessel way vessel
expand reliev obstruct stent may place depend
oper discret vessel prep dcb era gain traction sens
allow full dilat lesion dcb full coverag without
signific dissect frank perfor mitig need stent
endovascular intervent goal minim dissect recoil therebi
optim result angioplasti increasingli howev new technolog re-
emphas central role vessel prep optim outcom result
case surpris exampl recent trial dcb technolog
demonstr patenc plain old balloon angioplasti poba better
histor expect attent paid long low-pressur inflat similarli
outcom nitinol stent also like better adequ vessel prepar
optim prepar allow nomin stent deploy without area under-expans
stent elong sophist techniqu atherectomi use
specialti balloon score focal forc cut balloon also improv
trial patient success predil without dissect
perfor enrol therefor presum outcom base
devic also degre predil select larg number
patient presum success predil clearli real-
world approach given real world predil necessari actual
intervent either way mani observ seem infer outcom base data
without consid patient enrol criteria predil
type devic use vessel prep
choic vessel prep devic balanc devic safeti
potenti add efficaci current standard second consider
base whether oper experi use vessel prep devic
mani vessel prep devic bit difficult handl compar standard
pta balloon standard nitinol stent oper need feel comfort use
devic also learn curv differ type vessel prep devic
exhibit approxim criteria select atherectomi tool
type vessel prep eccentr vs concentr lesion
anoth complic factor choic tool use vessel prep
direct atherectomi devic use treat eccentr lesion lithotripsi
concentr calcifi lesion unclear
answer question vari depend ask clinician use dcb
first dcb postdilat spot stent necessari done
case patient vessel prep might consid major need
vessel prep obviou analyz initi angiogram perform
intervent simpl noncalcifi focal lesion may benefit aggress vessel
prep form debulk devic vessel prep also necessari lesion
respons predilat mainli short fibrot stenot lesion tasc ii
indirect evid random dcb trial indic standard dcb angioplasti
preced standard balloon angioplasti probabl suffici
role vessel prep drug uptak
role vessel prep alter local drug deliveri complex one due interplay
lesion prepar drug deliveri develop restenosi avail
atherectomi devic provid benefit optim lumin gain either modifi
complianc vessel remov plaqu drug deliveri larger biolog
question whether devic also improv retent and/or depth drug
deliveri lesion question preliminari data devic suggest
better paclitaxel penetr vessel wall atherectomi whether
intervent reduc subsequ rate restenosi remain seen import
real studi point increas drug uptak plaqu
modif reason may due drug get wash dcb
inflat along drug get lost balloon deliveri lesion
site therefor leav rel littl drug transfer lesion lack
lipophil site sever calcifi lesion mean drug like paclitaxel least
theoret true bind site henc fractur calcium necessarili lead
increas drug uptak also remain unclear final drug uptak heavili
influenc type balloon inflat pressur drug excipi residu drug content
durat inflat hold time number inflat site
vessel prep devic tailor lesion type
imposs predict platform work best certain clinic scenario basic
cut balloon score balloon flex score cathet lithotripsi short lesion
best treat atherectomi eccentr lesion direct atherectomi longer
lesion flex cathet lithoplasti unclear
cost-effect data regard specialti balloon atherectomi devic
spars two major potenti area cost off-set includ reduc need stent
implant due dissect recoil could prevent improv
vessel prep potenti reduc rate target lesion revascular tlr
time studi need show benefit vessel prepar prior dcb angioplasti
sfa stent justifi addit cost specialti devic
long-term data effect vessel prep
although acut result debulk vessel prep appeal question remain
increment benefit durabl superior inflammatori cost plaqu
remov effect current devic lumen gain
vascular atherosclerot
sourc nation review cardiolog medic scienc monitor
vascular calcif vc patholog respons toxic stimuli involv metabol
substanc and/or inflammatori cell histor vascular calcif consid
passiv process result ca ion exceed solubl tissu fluid
therebi induc precipit deposit hydroxyapatit crystal howev vc
format consid complex activ control intracellular molecular process
involv differenti macrophag vascular smooth muscl cell vsmc
osteoclast-lik cell similar bone format calcium essenti ion mani
metabol pathway includ regul heart rate contractil neuron
activ endocrin system paradox genesi vc although store
primarili bone teeth calcium intak diet uptak
proport dietari content therefor excess ca result dietari
allow regularli surpass diseas state storag compromis
calcium may accumul variou organ spleen liver kidney circulatori
system deposit arteri intima media may eventu lead
obstruct atherosclerosi alter serum ca level concert
oxid stress caus local gener hydrogen peroxid promot
differenti vascular smooth muscl cell vascular wall osteogen
phenotyp alter also associ signific loss endogen
bone format pyrophosph induc inhibitor osteopontin circul
inhibitor fetuin-a
underli pathophysiolog mechan result vc broadli describ
elev serum ca level induct osteogenesi inadequ
inhibit miner process migrat differenti macrophag
vsmc osteoclast-lik cell studi involv vc shown calcium
deposit arteri wall report nearli american year age
vascular calcif risk factor similar atherosclerosi
hypertriglyceridemia increas decreas hdl obes hypertens
potenti genet role medial vc propos wherebi gene mutat
regul vsmc extracellular matrix phosphat product protein promot vc
hypothes
exhibit mechan vascular calcif
catheter cardiovascular intervent
vessel calcif process may classifi accord histolog structur
anatom locat etiolog structur histolog deposit may
structur bone cartilag tissu may appear amorph form
depend vessel wall layer one speak tunica intima calcif
especi unrel atherosclerot plaqu atherosclerosis-unrel
calcif tunica media medial arteri calcif monckeberg type latter
also call calcif urem arteriolopathi affect arteriolar vessel wall lead
develop organ insuffici failur etiolog calcif divid
metastat dystroph former type occur concentr calcium
phosphat increas affect healthi tissu typic accompani
diseas hyperthyroid neoplasm etc latter type appear normal
concentr calcium phosphat damag necrot tissu
intim calcif common form calcium accumul particularli
person demonstr risk factor atherosclerosi develop also patient
suffer chronic hypertens osteoporosi calcium accumul initi
increas atherosclerot plaqu modifi lipid content pro-inflammatori cytokin
phosphat lipoprotein complex well foci necrosi
vitro studi shown pro-inflammatori cytokin oxid low-dens
lipoprotein monocyte/macrophag releas product promot osteogenesi
accumul calcium deposit vitro condit calcifi vascular
cell cvc subpopul smooth muscl cell osteoblast characterist
spontan form bone miner present atherosclerot plaqu may spontan
produc miner cluster local small lump histolog resembl
atherosclerot plaqu lesion origin heart valv cusp area densiti
calcif foci depend presenc stimul inhibitor calcium
accumul increas concentr transform growth factor beta tgf-b vitamin
warfarin increas number size calcif foci teleolog
function intim calcif may isol interrupt progress abnorm
obstruct stenot intim lesion may lead decreas organ perfus
dystroph calcif often affect aortic valv result long-standing
action mechan stress pro-inflammatori factor proven
connect tissu calcifi aortal valv stroma demonstr disturb organ
macrophag t-lymphocyt infiltr progress chang
cellular molecular analysi valv reveal osteoblastogenesi presenc
calcif vascular cell presenc chronic inflamm marker increas express
osteopontin bmp matur bone tissu
medial calcif widespread lower abdomin region primarili
associ peripher arteri diseas result osteogen differenti
vascular smooth muscl cell within medial layer vessel wall ca
accumul begin amorph miner deposit undergo progress
remodel ultim miner matur bone although medial calcif
gener associ lumin obstruct decreas arteri wall elast
complianc may ultim lead atherosclerosi reduc perfus eventu
coronari peripher arteri diseas intens calcium-phosph accumul
occur muscl layer blood vessel patient diabet chronic renal
diseas proven advanc medial arteri calcif connect
increas risk sudden cardiac death lower limb amput due vascular
insuffici diabet free oxygen radic induc develop chronic
inflamm adventitia lead infiltr connect tissu macrophag
t-lymphocyt
hyperglycemia glycosyl end product increas product tumor necrosi
factor tnf-a osteopontin opn increas express
gene express particularli aris adventiti myofibroblast
opn aris muscl cell tunica media inflammatori mediat stimul
prolifer osteogen differenti migrat myofibroblast tunica media
result thicken remodel calcif layer end-stag renal
diseas excess calcium phosphat ion stimul osteogen differenti
via signal pathway inorgan phosphat stimul vsmc
differenti cvc activ sodium-depend phosphat transport
subsequ cascad pathway import role
calcif attribut metalloproteinas mmp secret
inflammatori cell adventitia tunica media caus increas elastin
metabolit turn activ monocyt thu intensifi inflammatori
process degrad product may becom crystal nucleat
initi format crystal nuclei
implic arteri calcif
vascular calcif describ previou section activ
complex process involv numer mechan respons calcium deposit
arteri wall lead increas arteri stiff puls wave veloc
turn increas cardiovascular diseas morbid mortal
mean arteri complianc base case studi shown rang
ml/mmhg healthi adult ml/mmhg heart failur patient arteri stiffen
well-known phenomenon caus factor includ age race vascular
calcif hypertens high salt intak exact chang arteri complianc
due vascular calcif alon studi although invers relationship
well-accept document anecdot
exhibit arteri complianc perfus
arteri complianc elast import concept physiolog perspect
primari rational arteri complianc energi storag smooth
variat arteri circuit specif exampl cardiac side
compliant aorta store energi systol releas diastol flow
peripheri continu throughout cardiac cycl vessel rigid pipe
forward flow would occur eject period
one-third cardiac cycl state otherwis blood pressur would time
higher period maintain output stiffen central arteri like aorta
crucial differ physic properti compar physiolog compliant arteri
translat complet differ hemodynam profil cardiovascular system
cardiac cycl
energi power gener left ventricl systol regard
sum blood volum replac stroke volum pressur increment
systol blood pressur complianc compart replac
 aorta declin energi compris pressur workload instead
volum due lack capac dilat physiolog situat part energi
transfer left ventricl store elast expans central arteri structur
stiffen central arteri possibl initi lead increas
systol pressur declin peripher blood suppli latter lead increas
left ventricular load eventu hypertrophi second physic featur stiffen
arteri increas veloc pressur wave gener systol
open aortic valv import differenti pressur wave
actual propag blood volum aorta latter much slower sinc
pressur wave reflect smaller arteri peripher arteri system
travers back opposit direct blood flow stiffen arteri
reflect pressur wave reach aortic root earlier eventu arteri stiffen
progress close peak pressur cardiac cycl augment peak
pressur central arteri induc increas cardiac afterload
addit trigger develop left ventricular hypertrophi
exhibit arteri elast clinic impact
puls pressur pp defin differ systol blood pressur
diastol blood pressur pp progress increas age due decreas arteri
complianc attribut calcif arteri wall multipl prior epidemiolog
studi shown increas pp correl cardiovascular morbid
mortal studi author hypothes puls pressur would strong
predictor aortic calcif
studi author identifi patient aortic pp measur cardiac
catheter non-contrast chest ct scan evalu presenc
calcium differ segment ascend aorta arch aorta descend aorta
quantifi patient calcif calcifi group compar patient
without calcif noncalcifi group term pp calcif complianc
result show mean total calcium score higher descend
aorta arch ascend aorta vs vs respect pp
strongest correl calcif descend aorta
calcifi group much higher pp noncalcifi group greatest
differ descend aorta mmhg lesser ascend aorta
mmhg least arch mmhg calcifi group
patient also much lower complianc noncalcifi group patient
greatest differ among group seen descend aorta ml/mmhg
follow ascend aorta arch snapshot result shown
exhibit order comparison mean aortic complianc subgroup use peripher puls
pressur associ calcium score invas aortic puls pressur
author make follow observations/hypothes
heterogen pattern thorac aortic calcif multipl mechan
propos includ alter low-density-lipoprotein cholesterol transport
increas turbul wall shear stress especi locat
descend aorta mani branch segment
instanc ascend aorta two branch right left coronari arteri
arch three branch brachiocephal right subclavian right common
carotid howev descend aorta multipl branch includ pair
posterior intercost arteri multipl arteri origin anteriorli includ
bronchial mediastin esophag pericardi branch well superior
phrenic arteri larger chang pp complianc observ patient
calcif descend aorta aortic segment direct
correl degre calcif chang pp arteri complianc
stratifi data group without calcif show presenc
calcif associ increas pp segment aorta
greatest signific chang observ descend aorta
decreas complianc seen differ segment aorta due presenc
calcif comparison two group one calcif one
without group gener lower complianc relationship
statist signific descend thorac aorta
median survival/follow-up time year mean rang
patient die calcif descend aorta
calcif either ascend aorta arch aorta
morbid mortal
arteri calcif directli implic increas morbid mortal
effect vc significantli pronounc patient diabet chronic
kidney diseas highlight one studi involv chronic kidney diseas ckd
make point vc amplifi outcom specif cohort patient studi
author blacher et al enrol ckd patient hemodialysi three
month clinic cardiovascular diseas six month
preced entri mean follow-up month data mortal obtain
entir cohort whose averag age time inclus year
follow-up patient continu form hemodialysi
one attribut includ analys arteri calcif
univari analysi also perform impact calcif cardiovascular
mortal presenc vc measur ultrasonograph common carotid
arteri abdomin aorta iliofemor axi leg highli echogen plaqu produc
bright white echo shadow consid calcif assess
presenc calcif complement post-anterior later fine-detail
radiograph abdomen pelvi arteri calcif femorotibi arteri
axi evalu soft-tissu nativ radiograph arteri calcif arteri
site quantifi absent present final score obtain
addit calcif studi zone final score rang absenc
calcium deposit calcif present arteri segment examin
calcif score independ check two observ good reproduc
exhibit probabl all-caus surviv accord calcif score
follow-up month cardiovascular non-cardiovascular
death occur univari multi-vari analys show presenc
arteri calcif increas common carotid arteri increment elast modulu
einc strongli independ predict outcom end-stag renal diseas
esrd author specif design studi determin causal
relationship arteri stiff atherosclerosi howev found
strong intercorrel paramet relat atherosclerosi burden
calcif score paramet relat arteri stiff common
carotid arteri einc although close relat paramet
increment predict valu term cardiovascular all-caus mortal beyond
signific interact two paramet
effect paramet constant whatev level author
admit method quantifi calcium burden rather crude one
like underestim true calcium load graphic depict all-caus surviv
accord calcium score shown
challeng treat vascular
sourc singh et al evtoday raghid et al annal vascular medicin
surgeri parikh et al cleveland clinic journal medicin mori et al jacc
vascular calcif regardless vascular bed alway signific
challeng procedur success treat pad/cad limit durabl
intervent vc also gener marker global atherosclerot burden
studi marker cardiovascular morbid mortal numer challeng
understand treat vc remain includ
limit understand calcium pad
continu grow bodi evid multipl pathway implic
vascular calcif pathway complex interrel involv
endocrin inflammatori hormon metabol process vascular
calcif biolog activ diseas process repres dead
diffus tissu calcif aris patholog condit lead systemat
genet autoimmun disord etc intim calcif atherosclerosi
associ patchi pattern calcif calcif featur advanc
plaqu may quit extens lead develop occlus diseas
consist relationship plaqu size complex degre
calcif calcif deposit promin plaqu older individu
abdomin aorta coronari arteri atherosclerot plaqu calcif enhanc
plaqu stabil decreas clinic event medial calcif hand
observ infanc character increas arteri stiff puls
pressur patient diseas remain asymptomat unless complic
atherosclerosi calciphylaxi arteri calcium deposit increas distal arteri
tree moreov medial calcif rel diffus vari wide degre
burden medial calcif caus stiffen arteri wall elast complianc
lead atherosclerosi reduc perfus peripher arteri diseas
cardiovascular mortal among patient especi end-stag renal diseas
multipl modal use non-invasive invas assess
calcif varieti vascular bed coronari arteri calcium score use ct
angiographi tool well accept predict futur cardiovascular event
peripheri ct mri highli sensit method assess degre extent
vascular calcif howev imag modal use contrast agent iodin
contrast ct gadolinium contrast mri associ potenti
nephrotox ct expos patient ioniz radiat ct angiographi
therefor remain import diagnost tool intravascular ultrasound
hand also wide avail measur degre extent calcium burden
howev ivu wide use uniform reimburs
associ expens fluoroscopi anoth tool use measur vc
howev underestim extent locat calcif superfici femor
arteri sfa particularli knee tibial arteri discrep
differ modal lack uniform framework assess calcium burden
complic proper understand type treatment impact particular
treatment peripheri though current understand calcium score driven
prospect adjud outcom data need develop calcif score
prospect data guid appropri therapi gener rule agre
heavier degre calcium burden greater impact procedur success
clear though rel impact medial vs intim calcium calcium
burden rel outcom
impact procedur success
exist literatur suggest calcif translat higher rate acut
procedur failur due vessel recoil and/or dissect requir adjunct
stent although adjunct stent repres acut procedur failur
evalu patient long term appear adjunct stent impact
patenc one year vs drug coat balloon alon howev data deriv
small-pati cohort still complet understand whether
spot stent area acut recoil and/or dissect oppos appli full-met
jacket appropri therapi address drug coat balloon failur
variou stimuli initi progress calcif may differ
depend upon stage plaqu well surround milieu intim
calcif coronari death vascular smooth muscl cell drive
forc behind microcalcif medial calcif peripheri loss inhibitor
miner mainli promot calcif along osteogen mechan
involv bone form protein interestingli enough degre calcif might
differ implic treatment coronari vs peripheri
coronari plaqu type complex increas greater degre lumin
narrow preval extent calcif event rate base
cardiac calcium score standard test call agatston test shown
previou exhibit exhibit coronari calcium strongli associ advers
outcom popul far better marker futur event risk
equat date clear howev whether relat calcifi
plaqu sourc event whether calcifi plaqu predict
presenc coronari diseas accur perhap crucial clinic question
regard coronari calcium score whether presenc predict plaqu
instabl stabil combin coronari imag patholog shown
type calcif locat extent well volum densiti
differenti effect clinic risk outcom gener spotti calcif seem
predict plaqu instabl coronari wherea heavi calcif correl
predict event rate peripheri hand problemat
calcium score tool also lack quantifi imag modal along
higher preval medial calcif make calcium burden assess
problemat unlik cardiac calcium score evolv rel better
score mechan marker outcom peripher calcium score virtual non-
exist moreov prospect studi could find specif talk
impact calcif outcom pad
vessel prep cad treatment
vessel prep coronari predominantli involv prep vessel either use balloon
angioplasti atherectomi facilit stent placement report dcb
approv coronari remain seen paclitaxel sirolimu
drug choic coronari unlik peripheri paclitaxel drug
choic vessel prep coronari primarili design address issu stent
malapposit vs underexpans underexpans refer size stent
wherea malapposit refer contact stent vessel wall influenc
acut chronic outcom post deploy bm de ivu predictor
earli stent thrombosi in-stent restenosi isr underexpand stent
inflow/outflow track diseas signific plaqu burden edg stenosi etc stent
malapposit long stent well expand although bigger better regard
stent expans less respect stent edg plaqu burden accept
procedur endpoint minimum stent area stent-edg plaqu burden
maxim probabl long-term patenc
challeng treat calcifi coronari lesion rel higher non-
calcifi lesion studi point coronari calcif present
pci case sever calcifi increas coronari calcif lead higher
advers event procedur failur due un-dilat lesion balloon ruptur vessel
dissect pci vessel ruptur perfor asymmetr malappos
underexpand stent also remain huge issu sever calcifi coronari lesion
seen outcom horizons-ami acuiti coronari calcium
studi patient incid mace directli correl sever calcium
frequenc restenosi tlr peri-procedur mi likelihood stent
exhibit calcium sever horizonsami acuiti coronari calcium
anoth key consider coronari stent remain stent underexpans
correl calcium load import exist literatur point greater
arc length thick calcium greater likelihood stent
underexpans calcium arc therefor present interest conundrum use
ivl quantifi calcium arc use ivl correl benefit
ivl use variou calcium arc clinic outcom shown exhibit stent
expans invers correl calcium arc
exhibit stent expans correl calcium arc
anoth key concept pci stent stent recoil balloon underexpans
stent deliveri system use semi-compli balloon manufactur
chart certain balloon certain pressur turn give idea nomin
diamet inflat pressur howev balloon certif done either air
water therefor usual factor resist arteri wall exampl
calcifi lesion arteri wall complianc definit poor therefor present
high resist deliveri balloon fulli inflat balloon underexpans
turn lead subsequ stent recoil under-deploy remain debat
extent stent recoil larger diamet vs smaller diamet arteri
studi shown smaller bore arteri may result greater balloon
underexpans larger bore arteri interest studi author et al
heart volume prospect angiograph studi conduct
lesion patient undergo pci stent quantit coronari angiographi
qca use measur minim lumen diamet deliveri balloon
stent deploy stent segment follow balloon deflat
snapshot balloon underexpans stent recoil shown
exhibit order deliveri balloon underexpans balloon/vessel ratio stent recoil
major find studi post-deploy stent minim lumen diamet
less predict manufactur complianc chart despit use
high inflat pressur stent deliveri balloon underexpans rel
complianc chart stent elast recoil result anoth mld reduct
balloon underexpans stent recoil similar irrespect refer vessel
diamet use higher inflat pressur semi-compli balloon could stretch
arteri wall balloon margin increas risk perfor vessel
dissect howev whether predilat prior stent improv final lumen
diamet post-stent remain seen studi rodriguez et al
cardiolog volume author note stent recoil balloon deflat
account loss acut lumen gain angioplasti
vessel prep pad
perhap one age-old mysteri treatment peripher arteri diseas
remain use vessel prep prior definit therapywheth stent angioplasti
dcb highlight variou vessel prep technolog note
convinc data vessel prep truli confer superior outcom endovascular
procedur acut result use debulk plu stent dcb vs debulk alon seem
quit appeal visual angiogram howev key question remain
outcom durabl superior vessel prep ration bodi evid
suggest definit studi done across therapi
across standard lesion set know sure vessel prep make durabl
differ endpoint across trial dispar patient select bia widespread
long-term follow-up non-exist studi name issu despit
issu cite vessel prep continu activ use pad treatment especi
leave-noth behind strategi employ last year
logic vessel prep pad base belief minim dissect maxim
lumin gain prepar vessel bed stent vascular mimet implant and/or
balloon angioplasti pad use sinc earli said
fascin note standard techniqu develop poba
date typic poba involv inflat plain balloon atmospher atm
pressur certain durat typic balloon usual overs
rel arteri depend oper prefer techniqu use
stretch arteri near lesion therefor increas acut lumen gain
use stent dcb use everi balloon angioplasti creat level
barotrauma vessel injuri vessel dissect frequent occurr depend
type lesion particular poba algorithm employ microdissect
occur either way especi calcifi lesion howev larger dissect
prevent sinc requir emerg stent open vascular surgeri earli
elast recoil frequent dissect poor primari secondari patenc rate long
lesion case requir bail-out stent limit balloon angioplasti
interest studi zorger et al vasc interv radiol author evalu
impact balloon inflat time acut outcom poba peripheri
key takeaway studi prolong poba inflat time reduc
dissect sever rate therefor reduc need intervent
result highlight exhibit next page significantli fewer major
dissect modest reduct residu stenosi observ
exhibit impact balloon inflat time outcom
anoth studi fujihara et al journal endovascular therapi volume
author util retrospect data registri show increas sever
sfa dissect neg correl primari patenc rate freedom
tlr presenc chronic total occlus lesion length composit well
durat follow-up affect outcom note though
retrospect registri henc conclus view framework
necessarili definit data studi vessel dissect link
poba use type dissect outcom data seem indic poba
result grade dissect higher
exhibit order dissect type poba dissect impact clinic outcom
fujihara et al journal endovascular therapi kobayashi circ cardiovascular intervent
atherectomi procedur perform debulk atherosclerot plaqu diseas
arteri usual combin low-pressur balloon angioplasti goal
minim plaqu shift avoid stent placement dens calcifi vessel
atherectomi use better prepar vessel prior stent order
prevent incomplet and/or eccentr stent expans differ atherectomi
devic design cut shave sand vapor atherosclerot calcifi plaqu
slightli differ indic depend lesion characterist
atherectomi tool differ mechan action requir differ skill set
sweet spot certain lesion set differ impact outcom
rel basi broadli speak four differ atherectomi tool direct
atherectomi rotat atherectomy/aspir laser ablat orbit atherectomi
devic advantag avoid barotrauma may decreas risk
neointim hyperplasia dissect distal embol remain concern
devic given devic requir retriev remov plaqu use distal
protect devic may need particularli case heavili calcifi lesion
score cut balloon variant poba microsurg nitinol blade
atherotom bond longitudin surfac balloon microsurg
blade balloon inflat make intent score vessel lesion allow
increas vessel complianc better stent expans presum moreov
score balloon lower inflat pressur compar poba therefor
expect less vessel injuri henc lower restenosi typic
score balloon mechan action shown exhibit
exhibit typic balloon moa poba moa balloon
typic score balloon local injuri score site therefor potenti reduc
trauma control dissect less slippag therefor medial layer
visibl disrupt endotheli layer remain intact convers poba result
multipl rip tear media endothelium get damag case
lead hematoma and/or neointim injuri cut balloon rel expens
higher profil difficult navig tortuou anatomi given stiffer natur
balloon
graidi present hellen institut cardiovascular diseas
vascular calcif coronari bane pci procedur complic
deliveri therapi also final outcom vascular calcif shown
directli influenc age irrespect co-morbid develop
coronari calcium scale agtaston score along implement within diagnost
space led greater emphasi manag tackl problem vascular
calcif coronari interestingli enough adapt-d studi evalu use
drug-elut stent calcifi coronari arteri showcas widespread preval
calcium coronari author note approxim one-third
coronari patient popul moderate/sever calcif patient pool
sever calcium find coronari calcium also increas last
year due primarili incorpor accept coronari calcium score final
exhibit order preval coronari calcif trend coronari ca diagnosi sever ca pci
seen exhibit previou page coronari vascular calcif
preval vari coronari bed vari degre howev age probabl
direct correl burden calcif exist evid indic
patient year age almost calcium least vascular bed
two-third calcif arteri bed complet analysi variou specif
kind coronari heart diseas preval stratifi bed age gender level
calcif beyond scope report
exhibit order tam coronariesu atherectomi use pciu
rise incid obes diabet age creat perfect storm peripher
vascular diseas also world-wide estim pad continu rise exponenti
treatment option chosen usual mix-and-match given complex
diseas lack rigor compar studi approach specif
report stick market believ address csi
exhibit order overlap pad cad presenc calcium arteri locat
us estim pad patient roughli one-quart
claudic roughli endovascular procedur
current perform sourc shockwav approxim sort
calcifi lesion outsid us anoth pad procedur perform
world-wide pad market interestingli estim around us
anoth ou number includ kind balloon drug elut stent drug
elut balloon atherectomi devic modal drug elut balloon deb
far fastest-grow categori space howev march dear
letter fda cite late mortal signal paclitaxel-co balloon
put paus modal crimp compound-annual-growth-rate year/year low single-digit
remain unclear deb resum upward trajectori least fda
put confirmatori guidanc use direb
use drug elut stent de remain preval above-the-kne atk case
despit concern stent fractur overal outcom de improv
year newer stent design greater radial strength facilit use de
combin atherectomi all-in market pad stratifi use devic
shown next page calcul ivl remain somewhat problemat
given ivl statu vessel prep balloon lack clariti price sustain
ivl balloon procedur also number shown next page specif
us includ procedur done office-bas set estim obl
set current account two-third overal volum therefor ad anoth layer
complex proper analys ivl given lack obl reimburs
exhibit order us pad preval approx pad market mm
compani report shockwav csi may investor present cdc gov intern journal molecular scienc volume oppenheim estim
orbit ii studi prospect multicent non-blind trial evalu safeti
efficaci orbit atherectomi use diamondback modifi calcifi
coronari lesion prior stent placement studi enrol patient key
inclus criteria target vessel refer diamet
stenosi stenosi evid clinic
ischemia via posit stress test ffr reserv valu ivu minimum lumen area
target lesion length fluoroscop ivu evid sever
calcium deposit requir total length calcifi portion least
patient exclud target vessel stent previou pci
recent mi chronic renal failur lvef use thrombectomi therapi embol
protect devic brachytherapi cut balloon allow primari
efficaci endpoint defin procedur success defin stent deliveri
residu stenosi without occurr in-hospit mace primari safeti
endpoint mace day defin compromis mi tvr cardiac death
secondari endpoint includ angiograph success facilit stent deliveri
residu stenosi without sever angiograph complic index
procedur well rate individu sever complic perfor persist slow
flow persist reflow abrupt closur index procedur
exhibit order primari efficaci endpoint orbit ii primari safeti endpoint orbit ii
primari efficaci safeti outcom highlight stent deliveri
success case less residu stenosi case in-
hospit mace mi rate present tct
medic confer princip investig present side-by-sid comparison
orbit ii angiograph complic rel boston scientif rotobl seen
sever dissect use diamondback perfor rate slow
flow persist no-reflow abrupt closur spasm etc
number compar favor exist literatur rotobl howev note
caution warrant make comparison sinc head-to-head
studi control set
exhibit angiograph complic orbit ii compar rotobl literatur
orbit ii lower rate in-hospit non-q wave q-wave mi
respect author also compar result publish literatur
rotobl stratifi calcium score specif studi point includ one
mosseri et al show rotobl non-q wave mi rate
studi referenc one clavijo et al studi sever calcifi lesion treat
de without rotat atherectomi found non-q wave mi ck-mb
uln rate rotat atherectomi de group rate
des-onli group mortal rate compar orbit ii abovement
studi sever calcifi lesion point favor outcom orbit atherectomi
compar rotobl tlr rate orbit ii compar rotobl tlr
rate mosseri studi clavijo studi subsequ analys
orbit-ii shown orbit atherectomi cost-effect durabl clinic
year follow-up safeti efficaci benefit seen orbit ii maintain
year supplement cost-effect therapi per publish report
chamber et al scai exhibit showcas longer term
exhibit order two-year safeti data orbit ii efficaci data
eclips prospect random center trial design evalu vessel
prepar diamondback coronari classic crown compar
convent balloon angioplasti techniqu prior stent implant treatment
sever calcifi coronari arteri lesion approxim patient sever
calcifi coronari lesion enrol approxim site us
imag cohort consist approxim subject per arm oct
assess acut minimum stent area conclus procedur co-
primari endpoint includ acut defin in-stent minim cross-sect area
assess oct conclus procedur oct imag cohort
year target vessel failur tvf defin composit cardiac death target vessel
relat myocardi infarct ischemia-driven target vessel revascular
secondari endpoint includ procedur success defin success stent deliveri
final lab defin timi flow angiograph in-stent diamet stenosi ds
absenc follow stent loss coronari perfor
intra-procedur death strategi success defin procedur success without
crossov altern treatment trial flowchart shown current
expect trial enrol complet although suspect
date go slip
liberti prospect observ multicent studi evalu procedur
long-term clinic econom outcom endovascular intervent
patient symptomat lower-extrem pad oper could treat patient
endovascular devic fda-approv treatment pad lesion within
extend target area cm medial epicondyl digit arteri
includ diseas vessel locat within extend distal superfici
posterior tibial pt peron tibial pr arteri endpoint procedur
lesion success major advers event mae duplex ultrasound du qualiti life
qol six-minut walk test outcom includ rate follow
mae defin death within day index procedur unplan major
ankl amput target limb clinically-driven tlr target lesion revascular
and/or tvr target vessel revascular target limb
three year patient variou stage peripher arteri diseas underw
endovascular intervent high rate freedom advers limb event
outcom shown exhibit
exhibit three-year outcom liberti subgroup analysi year wound heal primari patenc
calcium prospect random multi-cent studi compar
acut long-term result orbit atherectomi system percutan
translumin angioplasti pta versu pta alon calcifi below-the-kne lesion fifti
critic limb ischemia patient enrol us site random either oa pta
patient pta alon patient follow month result
show mean balloon pressur lower use conjunct
pta mae lower pta arm
exhibit order mean mx balloon inflat pressur rate bailout stent freedom
complianc prospect random multi-cent studi compar
acut long-term result percutan translumin angioplasti pta vs
pta alon calcifi above-the-kne atk lesion fifti patient enrol us
site random either oa pta patient pta alon patient
follow month outcom studi shown
exhibit order mean max balloon inflat pressur adjunct stent patenc month
american heart associ aha american colleg cardiolog
issu updat guidelin focus updat
manag diagnosi lower extrem pad european societi
cardiolog esc togeth european societi vascular surgeri esv
updat comprehens guidelin discuss
differ guidelin recommend particular interest evid
base although organ organ level evid
random control trial nonrandom studi acc/aha inclus
smaller well-don nonrandom studi wherea esc/esv releg small
studi level evid differ drive variat therapeut
recommend factor diverg approach revascular
exampl driven greater relianc nonrandom studi acc/aha
document specif delv differ diagnosi pad medic
manag matter anticoagul relev report
home differ approach revascular pad
exhibit order differ guidelin intermitt claudic ali
continu follow two page
list variou reimburs code use bill orbit
atherectomi inpati obl set note chatter
revisit ruc valu assign code process revisit
code includ formal process undertaken ama http //www ama-
seem
csi reimburs rate stay put
continu follow four page
direct atherectomi plaqu remov guid cut devic cutter
cathet directli plaqu rotat cathet prefer direct
devic accomplish target atherosclerot plaqu remov advantag
treat eccentr lesion reason plaqu volum remov multipl
pass remov plaqu pack nosecon pass
cathet must retriev nosecon must empti order proceed
debulk silverhawk turbohawk hawkon direct atherectomi
plaqu excis system approv use peripher arteri lesion
silverhawk side-cut cut devic cathet equip singl
rotat blade within tubular cover end nosecon collect area
rotat blade power motor within capit equip turbohawk
similar system four contour blade achiev plaqu remov
pass provid aggress atherectomi advantag treatment
sever calcifi lesion hawkon recent direct atherectomi
cathet seri design provid effect treatment
calcifi lesion one-blad platform lower cross profil equip
preload distal flush tool simplifi clean process necessit fewer
procedur step less time provid two time cut effici
turbohawk although devic aspir mechan major
excis plaqu collect within nosecon nosecon full devic
must retriev empti use nevertheless distal embol
remain issu devic use without appropri protect arteri filter
advis three devic avail variou size use vessel
diamet rang mm
philip enter atherectomi space acquisit spectranet
spectranet manufactur market excim laser use non-calcifi
lesion laser atherectomi use excim laser technolog ablat atheromat
power turbo-tandem use ultraviolet radiat remov atheroma arteri
lumen thick puls energi excim laser technolog
util low penetr depth puls deliveri high energi achiev
disrupt atheroma contact laser without damag
surround arteri tissu laser atherectomi indic de novo in-stent
philip turbo tandem devic design use total subtot occlus
turbo-elit cathet capabl cross occlus without need
guid wire cathet diamet rang mm compat
sheath devic power extern gener excim laser
ablat system effect ratio respect catheter/vessel
diamet cathet advanc also import deliv appropri amount
energi lesion perform slowli rate mm/
remov plaqu effect uniformli importantli laser never use
presenc contrast media increas energi absorpt lead dissect
perfor blood also absorb laser energi salin flush laser
atherectomi essenti order remov blood contrast treat vessel
micro- macro-embol describ use protect filter
exhibit cross-sect excim laser energi deliveri
manufactur market rotobl jetstream rotat
atherectomi devic rotat atherectomi plaqu excis concentr
rotat special design tip burr result lumin gain usual match size
tip/burr use larger lumen necessari larger cathet tip/burr
util pathway jetstream pv atherectomi cut rotat
atherectomi devic activ debri aspir indic acut thrombu
remov atherectomi chronic lesion sheath over-the-wir system
two type cathet sc cathet smaller equip singl set
front cut blade larger xc cathet equip second set larger
blade proxim front cut set use order increas diamet
debulk effect atherectomi aspir port situat proxim
larger blade even proxim infus port enabl flush
jetstream consol design enabl atherectomi activ aspir flush
monitor volum blood product remov despit activ aspir
micro- macro-embol possibl filter protect advis
peripher rotabl system consist outsid consol rotat concentr
diamond-co cathet tip uniqu featur devic
lumin gain predefin match size burr rang mm
creat smooth lumen specif diamet howev guid
integr cathet narrow lesion may difficult cross cathet requir
arteri sheath compat specif guid wire
maximum atherectomi time recommend singl cathet minut
burr consid ineffect activ aspir avail diamond-co
burr macer atheroma debri smaller red blood cell usual
incit clinic signific embol nevertheless filter protect recommend
eximo medic acquir angiodynam eximo b-laser util short
puls nm laser platform cross highli calcifi lesion use step-
by-step techniqu without need cross wire first challeng scenario
includ long sever calcif lesion system util third harmon nd
yag laser coupl single-us hybrid cathet oper laptop hybrid
oper realiz way laser compon appli enough highli
precis energi allow penetr mechan tip mechan tip gentli
complet separ process cathet continu progress detach
block deposit tissu laser emit nm puls durat
puls nanosecond full-width-half-maximum repetit rate hz
beam diamet mm coupl cathet use dedic optic
hybrid cathet outer diamet mm length abl deliv
guidewir diamet contain multimod optic fiber
core diamet blunt mechan blade optic fiber deliv
averag fluenc per puls slightli typic
ablat threshold calcifi tissu use ns puls nm
therefor cathet capabl deliv overal energi mj event
intravascular lesion obstruct cathet forward movement blood
vessel laser compon ablat ten micron tissu make
thin shallow slit enabl continu penetr blunt mechan blade
blade therefor design blunt initi dissect enough
edg enabl deeper cathet penetr tissu achiev
border tissu ablat possess transient zone mechan
weaken due trauma facilit dissect blunt blade b-laser
evalu pivot studi compar outcom follow either plain old
balloon angioplasti poba drug-coat balloon dcb clinic
characterist similar two group poba patient poplit
tibial lesion treat vs dcb group
lesion characterist similar major procedur complic
includ embol grade ce dissect labadjud duplex
patenc six month poba group dcb group one-
year clinic improv ankle-brachi index rutherford score
medic revolut peripher atherectomi system low-profil rotat
atherectomi system rpm continu mechan aspir btk
atk applic includ multipl plaqu morpholog rang thrombu soft
plaqu sever calcifi lesion devic oper
power suppli similar size laptop comput charger requir capit
equip minim setup time prior use privat held medic receiv
clearanc septemb base result reveal trial
primari object reveal trial evalu safeti effect
revolut peripher atherectomi system patient symptomat infrainguin
lower extrem arteri obstruct diseas one hundr twenty-on patient
enrol us site patient rutherford categori diseas lesion
stenosi elig primari safeti endpoint composit
revascular amput vessel perfor embol primari
effect endpoint technic success defin core laboratoryassess
diamet stenosi treatment prior adjunct therapi
primari safeti effect endpoint met freedom
day major advers event intention-to-treat patient day
distal embol clinic event committe adjud non device-
relat technic success target lesion exclud lesion
treat burr appropri size vessel diamet data set
post-atherectomi stenosi technic success rate
patient non-imput procedur success rate
patient six-month outcom also favor
choic atherectomi devic depend plaqu locat vessel characterist
length diseas segment plaqu quantiti plaqu textur physician experi
broadli speak four type atherectomi tool market three
shown exhibit
exhibit comparison atherectomi devic
retrospect analysi peripher vascular diseas databas
case vascular qualiti initi organ studi evalu use
atherectomi infrainguin pad comer jan dec three
group identifi wereorbit vs excision direct vs laser atherectomi
flowchart baselin characterist shown exhibit
exhibit order flowchart vqi pvi registri analysi
clinic procedur outcom shown exhibit note
comer retrospect registri analysi henc result taken within
context real-world scenario key takeaway patenc rate
atherectomi devic rang roughli among differ
modal orbit atherectomi low rate use embol protect devic
direct atherectomi rate use final orbit atherectomi
lower stent use direct laser atherectomi overal
exhibit clinic outcom registri analysi
comparison atherectomi pad
analysi author katsano et al provid summari variou clinic trial
registri analys peripher atherectomi space summari
result highlight next exhibit specif author note
shamma et al journal endovascular therapi volume
publish outcom calcium rct compar primari balloon
angioplasti vs silverhawk direct atherectomi adjunct balloon
angioplasti patient suffer intermitt claudic ic patient
critic limb ischemia patient major case
patient involv femoropoplit lesion remain
infrapoplit lesion also treat primari endpoint studi
set target lesion revascular tlr year secondari endpoint
includ technic success bailout stent rate target vessel
revascular tvr technic success angioplasti arm
versu atherectomi arm follow-up tlr vs
tvr vs similar atherectomi angioplasti
arm respect small numer benefit favor direct
atherectomi howev atherectomi plu angioplasti result significantli less
bailout stent due sub-optimal immedi technic result vs
hand distal macro-embol significantli higher
atherectomi arm vs
anoth multicent rct publish dattilo et al journal
cardiolog volume report immedi midterm outcom orbit
atherectomi plu balloon angioplasti compar balloon angioplasti alon
patient calcifi femoropoplit lesion studi primari
endpoint freedom tlr includ adjunct stent duplex
ultrasound du -defin restenosi month stent deem necessari
atherectomi arm trial balloon
angioplasti arm freedom tlr includ adjunct stent
restenosi note versu month
versu year exclud adjunct stent
atherectomi balloon angioplasti arm trial respect
although less stent use note atherectomi yield superior outcom
compar standard balloon angioplasti
multicent rct dippel et al jacc cardiovascular intervent volume
patient present ic rutherford class due
isr random ratio undergo excim laser atherectomi ela
plain balloon angioplasti versu balloon angioplasti alon us
center primari efficaci endpoint tlr primari safeti
endpoint major advers event death amput tlr mean
lesion length similar around cm case total
occlus treat rate vessel present calcif
significantli higher ela arm vs ela result
superior procedur success vs freedom tlr
vs significantli fewer procedur complic
moreov ela associ tlr reduct author
conclud ela plu balloon angioplasti significantli improv acut
medium-term efficaci safeti outcom femoropoplit isr treatment
compar convent pta alon
exhibit summari registri trial peripher atherectomi
talon studi ramaiah et al journal endovascular therapi volume
involv us institut investig direct atherectomi
silverhawk devic patient limb ic due
femoropoplit and/or infrapoplit diseas mean lesion length mm
femoropoplit lesion mm infrapoplit lesion procedur
success atherectomi alon without adjunct treatment
perform lesion stent deploy necessari
lesion rate freedom tlr
follow-up respect accord multivari analysi histori mi
coronari revascular multipl lesion increas rutherford
categori signific predictor tlr lesion length mm
associ increas risk tlr lesion length mm
associ increas tlr
data definit le determin effect
silverhawk peripher plaqu excis silverhawk devic
treatment infrainguin vessels/low extrem publish mckinsey
et al jacc cardiovascular intervent volume largest
prospect multicent real-world registri conduct multi-national center
investig direct atherectomi infrainguin lesion cm
total patient primari endpoint primari patenc year du
assess independ core laboratori analysi claudic freedom
major unplan amput decid clinic event committe
patient suffer studi power non-inferior
assess primari patenc diabet versu nondiabet claudic
primari patenc year similar diabet
subgroup nondiabet subgroup vs freedom
major unplan amput rate peri-procedur advers event
embol perfor abrupt vessel occlus
bailout stent rate significantli less report
shamma et al nearli lesion calcifi approxim
case occlus treat
confirmatori compar studi call definit ar trial zeller
et al chare cross multicent random control trial
sponsor compar up-front atherectomi turbohawk
silverhawk plaqu excis system follow drug-elut balloon angioplasti
versu drug elut balloon singl approach patient rutherford
diseas due superfici femor and/or poplit lesion
patient random either direct atherectomi plu dcb group
filter protect daart paclitaxel-co balloon alon
 significantli lower flow-limit dissect rate note daart
arm vs need bailout stent one-
year restenosi rate du psvr without tlr evalu
independ core laboratori daart arm
dcb arm non-signific angiograph patenc stenosi
without tlr assess independ core laboratori
daart arm trial dcb arm definit ar provid
higher level evid regard possibl addit benefit perform
debulk atherectomi prior use drug-elut balloon
investig conclud definit ar result trend potenti
better outcom challeng lesion subset sever calcifi one
cm lesion
mahmood et al cardiovascular innov applic volume etc
coronari arteri diseas key segment activ util atherectomi tool
part techniqu might differ given differ vasculatur
anatom consider tool still samedirectional/orbit rotat
atherectomi note specif highlight ivl
balloon within categori simpli ivl atherectomi tool sinc
remov plaqu simpli special vessel prep balloon plaqu
modif view within context
summari coronari atherectomi studi author state lead role
atherectomi facilit higher rate procedur success heavili calcifi
lesion allow success pci clinic trial need establish
ad efficaci reduc long-term morbid and/or mortal snapshot
trial primari outcom shown
mahmood et al cardiovascular innov applic volume
past six year good growth trajectori
overal revenu increas compound-annual-growth-rate
approxim current revenu deriv us
peripher segment exit coronari segment grew y/i clip
peripher segment grow y/i notabl within us peripher
segment constitut approxim revenu note
within coronari segment higher peripher segment vs
fx exposur less net growth rate reflect higher unit growth
rate off-set low-single-digit price declin coronari side mid-singl
digit price declin peripher side exit compani ship
system world-wide estim coronari side
remain peripher segment
quarterli revenu trajectori profil shown exhibit pillar growth
csi continu train new physician coronari peripher side
introduc accessori product therebi increas revenues/cas capit
result eclips studi exploit growth segment
implement new product introduct end highlight rang
accessori product sold increment revenues/cas exhibit
compani prior guidanc withdrawn owe intern
revenu
given rel fragment atherectomi use coronari peripher side
number suggest csi done reason good job gain leadership
posit key segment note howev price differenti key factor
nomin dollar figur especi sinc boston scientif rotapro
almost cheaper csi devic end highlight unit volum
share us peripher coronari side csi effort introduc
accessori product success combin increas case volum
allow steadi unit share gain next year
gross margin csi remain healthi rang although single-digit
price declin anticip lower transfer price intern sale flow
margin profil end factor bp reduct
composit gross margin model driven product mix on-going price
declin manufactur effici realiz compani in-hous cost-
reduct program long term believ gross margin reason
exit sg stood sale respect high opex
expect continu part stori especi sinc number case
exhibit margin opex profil
compani prior guidanc revenu rang
intern revenu contribut howev guidanc withdrawn april
owe pandem first two fiscal quarter compani
gener prior guidanc consensu forecast reflect prior
guidanc howev state obviou on-going coronaviru shutdown social
life includ travel key geographi delay certain percentag elect
surgeri across board bound affect csi busi also sure
key segment within exempt categori mandat cardiac symptom
vascular limb salvag off-set csi us busi said
prudenc dictat adopt much conserv postur henc
number much lower consensu prior compani guidanc
highlight could end conserv busi return normal
within next week howev worri unknown greater
residu effect factor expect across board estim
revenu approxim lower consensu number
quarterli pro forma estim shown next exhibit
marginr sg cardiovascular system inc
scott ward member csi board director sinc serv
chairman sinc novemb august mr ward appoint presid
chief execut offic sinc mr ward one manag director
sightlin partner current provid limit advisori consult servic
sightlin partner capac employ
inc held number senior leadership posit mr ward senior vice
presid presid cardiovascular busi may
novemb prior senior vice presid presid medtron
vascular busi may may senior vice presid presid
medtron neurolog diabet busi februari may
presid medtron neurolog busi januari januari
vice presid gener manag medtron drug deliveri busi
prior led medtron neurolog ventur success
develop new therapi
mr point join csi septemb corpor control becam senior director
control juli corpor control treasur januari vice
presid corpor control treasur may promot chief
financi offic februari juli septemb assist
control empi manufactur provid non-invas medic product pain
manag physic rehabilit januari juli mr point
held variou leadership posit clifton larson allen nation public account
firm mr point also serv member board director phoenix
ms robb join csi chief oper offic januari bring
year medic devic leadership compani prior csi held sever
posit recent vice presid gener manag heart
valv therapi busi includ transcathet aortic valv busi previou
role ms robb held leadership posit medtron coronari peripher
cardiac rhythm heart failur busi
initi coverag cardiovascular system outperform rate
price target pt deriv use multipl sale
estim cardiovascular system repres strong pure play
atherectomi marketplac two key target market coronari peripher arteri
diseas continu market penetr accessori product introduct use exist
case potenti increas revenues/cas per case intern
market growth distributor partnership orbu neich medikit final
call option pvad program provid necessari ingredi steady-
eddi long-term growth stori henc begin outperform pt
exhibit forward price/sal vs small-cap univers
oppenheim co factset estim
csi compet number larger player
philip henc execut risk integr part stori
biggest short-term risk horizon unknown collater damag
coronaviru accordingli lower number compani recent
withdrawn due guidanc account potenti impact
eclips repres huge larg opportun stori potenti
number
sale
sg
number
properti plant equip
accumul comprehens incom
stock price compani mention report
